Position in GALT
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$37,667
-$15,967 QoQ
Shares Held
13,501
+4.7% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Archer Investment Corp holds $853,623 across 20 Biotechnology names. GALT ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
6,546 | $321,081 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
730 | $188,573 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,000 | $64,630 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
449 | $55,967 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
600 | $45,054 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
5,872 | $45,038 | |
| 7 | GALT |
Galectin Therapeutics Inc
This page
|
13,501 | $37,667 | |
| 8 | MRNA |
Moderna, Inc.
|
520 | $26,416 |
All Filings in GALT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,667 | 13,501 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $53,634 | 12,893 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $46,640 | 11,000 | Shares | Sole | 2025-11-03 | |
| No filing history on record for this holder in this stock. | ||||||